Evidence map›Paper›PMID 20716966›Full record

ArticleCell cycle (Georgetown, Tex.)2010

Deregulated Ras signaling compromises DNA damage checkpoint recovery in S. cerevisiae.

Matthew D Wood, Yolanda Sanchez

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Ras signaling in yeast.Genes & cancer · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Matthew D WoodDepartment of Pharmacology and Toxicology, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH, USA.
Yolanda Sanchez
Dartmouth College · USDartmouth Hospital · GB

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Cancer Biology and Molecular TherapeuticsT32CA009658 · NCI · DARTMOUTH COLLEGE · PI EASTMAN, ALAN R · 1991 to 2011
$3.8M
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYSR01CA084463 · NCI · UNIVERSITY OF CINCINNATI · PI SANCHEZ, YOLANDA · 2000 to 2009
$2.7M
Identification of Drug Targets for NF1R21NS060940 · NINDS · DARTMOUTH COLLEGE · PI SANCHEZ, YOLANDA · 2009 to 2010
$388k
NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA084463NCI NIH HHS R01CA84463NCI NIH HHS T32 CA009658NCI NIH HHS T32-CA009658-18NINDS NIH HHS R21NS06094NINDS NIH HHS R21 NS060940
6 · The paper itself

Abstract

The DNA damage checkpoint maintains genome stability by arresting the cell cycle and promoting DNA repair under genotoxic stress. Cells must downregulate the checkpoint signaling pathways in order to resume cell division after completing DNA repair. While the mechanisms of checkpoint activation have been well-characterized, the process of checkpoint recovery, and the signals regulating it, has only recently been investigated. We have identified a new role for the Ras signaling pathway as a regulator of DNA damage checkpoint recovery. Here we report that in budding yeast, deletion of the IRA1 and IRA2 genes encoding negative regulators of Ras prevents cellular recovery from a DNA damage induced arrest. The checkpoint kinase Rad53 is dephosphorylated in an IRA-deficient strain, indicating that recovery failure is not caused by constitutive checkpoint pathway activation. The ira1Δ ira2Δ recovery defect requires the checkpoint kinase Chk1 and the cAMP-dependent protein kinase (PKA) catalytic subunit Tpk2. Furthermore, PKA phosphorylation sites on the anaphase promoting complex specificity factor Cdc20 are required for the recovery defect, indicating a link between the recovery defect and PKA regulation of mitosis. This work identifies a new signaling pathway that can regulate DNA damage checkpoint recovery and implicates the Ras signaling pathway as an important regulator of mitotic events.

Indexed as

DNA DamageSignal TransductionCatalytic DomainCdc20 ProteinsCell Cycle ProteinsCheckpoint Kinase 1Checkpoint Kinase 2Cyclic AMP-Dependent Protein KinasesDNA RepairGTPase-Activating ProteinsMitosisPhosphorylationProtein KinasesProtein Serine-Threonine Kinasesras ProteinsSaccharomyces cerevisiaeCdc20 ProteinsCDC20 protein, S cerevisiaeCell Cycle ProteinsCheckpoint Kinase 1Checkpoint Kinase 2Cyclic AMP-Dependent Protein KinasesGTPase-Activating ProteinsIRA1 protein, S cerevisiaeIRA2 protein, S cerevisiaeProtein KinasesProtein Serine-Threonine KinasesRAD53 protein, S cerevisiaeras ProteinsSaccharomyces cerevisiae ProteinsTPK2 protein, S cerevisiae

Identifiers

PMID20716966
PMCPMC3041168
OpenAlexW2045219100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.